2020 in Hindsight: Clinical Trends and Predictions
We will all remember 2020 for its startling impact on everyday life, from new work norms to how we receive medical care. The workers’ compensation and auto casualty industries have grappled with work-from-home requirements, increased unemployment, telehealth adoption and additional challenges with patient care and recovery. When it comes to pharmacy care, the pandemic has brought forth some issues while placing others on the backburner. This review will examine how the COVID-19 pandemic has affected the industry from a pharmacy perspective and what trends we expect to influence 2021.
Specialty Medication Trends
1 MIN READ
Specialty medications, which are typically used to treat patients with complex, chronic conditions, continue to be a major area of pharmaceutical development and can have significant costs.
2021 Regulatory Predictions for Auto Casualty and Workers’ Comp [Podcast]
On-Demand
In 2020, the workers' compensation and auto casualty regulatory environment was more active than ever—since the start of the COVID-19 pandemic, U.S.
Price Opportunists - Compound Kits and Combo Packs
2 MIN READ
This week’s look back at 2019 drug trends is at compound kits and combo packs.
Prescription and Private Label Topical Trends in 2019
1 MIN READ
These and other challenges call for careful oversight that includes identification, clinical review and intervention, and/or recommendation of therapeutic alternatives where appropriate to help control inappropriate utilization and spend.
At the eye of the storm: An opioid overdose epidemic and a viral pandemic converge
2 MIN READ
s 2020 opened, a persistent and tragic opioid overdose epidemic was near the front of a list of national concerns in the US. Some 20+ million Americans are reported to have a substance use disorder and 2M of those misuse opioids.
Opioid Risk Mitigation: Medication-Assisted Treatment (MAT) and Naloxone
2 MIN READ
This week in our in-depth review of our Coventry Drug Trends series, part three, we focus on opioid risk mitigation strategies. While opioids continue to decline in workers’ compensation as both a percentage of total script volume and costs, it remains vital to promote evidence-based strategies such as MAT and naloxone to curb opioid issues.